Can you test in production, or do you need a staging clone?

Both work. Production testing is supported with synthetic test accounts, coordinated rate limits, and a written rules-of-engagement. A staging clone is faster and lower-risk if it mirrors production configuration. We help you decide on the scoping call.

How do you handle PHI during testing?

We don't exfiltrate real PHI. Testing uses synthetic accounts wherever possible. When we identify a PHI exposure, we document the path and prove the issue with metadata only - never with real patient records. We sign a BAA on request.

Do you need IAM access to our cloud?

Read-only IAM access in the environment under test dramatically accelerates the engagement and produces deeper findings. We can run a fully external black-box test, but expect to find less in the same window.

Will this satisfy HIPAA Security Rule requirements?

We test the HIPAA Security Rule technical safeguards (access control, audit, integrity, transmission security) and produce evidence aligned to each. HIPAA isn't a certification - but our report is the evidence your compliance team needs for the risk analysis and for SOC 2 / HITRUST work.

What about FDA cybersecurity expectations?

Connected devices with cloud backends fall squarely inside FDA's Feb 2026 premarket guidance. Our findings are mapped to your AAMI TIR57 threat model and threat-model controls so reviewers see end-to-end coverage.

Do you cover IoT Core / IoT Hub specifically?

Yes. Device certificate provisioning, MQTT topic ACLs, message routing, and rule-engine logic are all in scope when the device channel is included. This is one of the highest-yield areas in connected-device backends.

Do you sign a Business Associate Agreement (BAA)?

Yes. We sign a BAA before any engagement that may incidentally expose us to PHI. In practice we structure work to avoid PHI exposure entirely.

Can the report serve as SOC 2 evidence?

Yes. We map findings to SOC 2 Common Criteria (CC6 logical access, CC7 system operations, CC8 change management) so your auditor can use the report as evidence in their next examination.

What clouds do you cover?

AWS, Azure, and GCP - including the IoT services, managed identity systems, KMS equivalents, and serverless platforms on each. We can assess one cloud or all three in a single engagement.

How does this fit alongside your firmware or BLE/RF service?

Most connected devices benefit from all three. PHI Cloud covers what happens after data leaves the device. BLE/RF covers the wireless transport. Firmware covers the device itself. Bundle for full coverage, or scope à la carte to fill a specific gap or deficiency.

À La Carte Cloud Backend Pen Testing

PHI Cloud Pen Testing. Built for Connected Devices.

Targeted cloud backend testing for connected medical devices that store or transmit PHI - APIs, IAM, tenant isolation, KMS, and IoT brokers. HIPAA-aligned, FDA reviewer-ready, and SOC 2 evidence-grade.

AWS · Azure · GCP. HIPAA + FDA + SOC 2 evidence in one engagement.

Device-to-cloud APIs
IAM & tenant isolation
KMS & secrets
MQTT / IoT brokers

Scope My Cloud Pen Test

Free 30-min scoping call
Fixed-fee quote in 24 hours
Senior cloud + healthcare specialist
AWS / Azure / GCP coverage
Re-test included

Trusted by leading MedTech companies since 2014

Reviewed by Christian Espinosa, MBA, CISSP · Founder & CEO

Last reviewed May 2026

Why Generic Cloud Pen Tests Miss the Real Risk

A standard cloud pen test focuses on a web app and its REST API. Connected medical devices add a device-to-cloud channel, multi-tenant data isolation, and PHI handling - risks generic engagements aren't scoped for.

Device Channel Untouched

MQTT brokers, IoT Core, and device certificates are different from a web API. Most pen tests skip them entirely.

No Tenant-Isolation Testing

Cross-tenant data leakage is the #1 risk for multi-org platforms. It requires a deliberate test matrix, not a single-account scan.

HIPAA Mapped, Not Tested

Generic firms hand you a HIPAA mapping spreadsheet. We test whether the technical safeguards actually hold under attack.

What's included

Reviewer-ready deliverables in one engagement

Every phi cloud backend penetration testing engagement ships with the artifacts FDA reviewers expect to see - traceable, complete, and aligned with current guidance.

Device-to-cloud API authentication and authZ
Tenant isolation and multi-org boundary testing
AWS/Azure/GCP IAM, KMS, and storage misconfig review
PHI data-flow tracing and exposure analysis
HIPAA technical safeguard validation
MQTT, AMQP, and IoT broker abuse cases

Attack surface

What We Actually Test

Scope is à la carte - pick the cloud surfaces in your device's backend. We can assess one cloud or all three.

Device-to-Cloud Channel

Device authentication (X.509, JWT, mutual TLS)
Certificate provisioning and rotation flow
MQTT / AMQP topic ACLs and wildcards
AWS IoT Core / Azure IoT Hub / GCP IoT Core review
Replay, spoof, and rogue-device scenarios

API & Authorization

REST / GraphQL endpoint enumeration
Object-level authZ (BOLA / IDOR) at scale
Function-level authZ (BFLA) and role boundaries
Token lifecycle, refresh, and revocation
Rate-limit, mass-assignment, and SSRF

Tenant Isolation & PHI

Cross-tenant data access matrix
Org-boundary leakage in shared resources (queues, caches)
PHI data-flow trace from device to storage to UI
PHI in logs, metrics, and error responses
Backup, snapshot, and export-path PHI exposure

Cloud Infrastructure & Secrets

IAM least-privilege audit (AWS / Azure / GCP)
KMS / Key Vault / Cloud KMS key policy review
S3 / Blob / GCS bucket exposure and misconfig
Lambda / Functions / Cloud Run inspection
Secrets in code, config, and CI/CD pipelines
VPC, security group, and network ACL review

How it works

Engagement Methodology

Three to five weeks. Read-only IAM access in your non-prod (or prod, with safeguards) accelerates everything.

01

Scoping & Architecture Review

We review your cloud architecture, PHI data-flow diagram, threat model, and HIPAA risk analysis. We agree on environment (staging vs. prod), test windows, and PHI-handling rules.
02

Reconnaissance & Configuration Review

Read-only IAM audit, infrastructure-as-code review where available, and external attack-surface enumeration. We map every PHI-touching service.
03

Active Testing

API authZ matrix, device-channel attacks, tenant-isolation probing, secrets hunting, and PHI exposure tracing. All testing scoped to avoid PHI exfiltration - synthetic accounts only where possible.
04

FDA + HIPAA + SOC 2 Reporting

Findings mapped to FDA Feb 2026 guidance, HIPAA Security Rule technical safeguards, and SOC 2 CC controls. One report, three evidence packages. Re-test included.

Pricing guidance

Pricing Guidance

Fixed-fee. Cloud scope scales with surface area, not just lines of code.

Single-Cloud, Single-Tenant

$15k – $30k

One cloud (AWS or Azure or GCP), single-tenant deployment, modest API surface, no IoT broker or limited MQTT scope.

API authZ matrix (up to ~30 endpoints)
IAM + KMS + storage configuration review
PHI data-flow trace
HIPAA technical-safeguard validation
One round of re-test

Multi-Tenant SaaS

$30k – $60k

Most connected-device platforms: multi-tenant, device-to-cloud channel, ~50–150 API endpoints, IoT Core / IoT Hub in scope.

Full tenant-isolation matrix
Device-channel + MQTT topic ACL testing
Cross-tenant PHI exposure probing
IaC review (Terraform / CDK / Bicep) where available
Two rounds of re-test

Multi-Cloud / Enterprise

$60k – $120k+

Multi-cloud or hybrid deployments, enterprise IDP federation, complex data-residency requirements, or high-volume IoT fleets.

Per-cloud configuration audit
Federated identity + SSO boundary testing
Data-residency and cross-region PHI flow review
Dedicated senior cloud + healthcare lead

What drives the price

Number of clouds in scope (AWS / Azure / GCP)
Number of API endpoints and microservices
Multi-tenancy model (shared schema, schema-per-tenant, account-per-tenant)
Device-channel protocol (HTTPS, MQTT, AMQP, custom)
Test environment (production with safeguards vs. staging clone)
Whether infrastructure-as-code is available for review
PHI volume and data-residency constraints

Production testing is supported with PHI-safe test accounts and rate-limit coordination. We never exfiltrate real PHI.

Get a fixed-fee quote

FAQ

PHI Cloud Backend Pen Testing FAQs

In their words

Backed by MedTech leaders.

"Blue Goat Cyber's depth of expertise was impressive. We had no in-house cybersecurity experience, and their team guided us through every step of the FDA process. The penetration testing and SBOM testing were thorough and gave us complete confidence."

Hank Tucker

CEO · MedTech Manufacturer

Ready to start PHI Cloud Backend Penetration Testing?

PHI Cloud Backend Penetration Testing - scoped, fixed-fee, FDA-ready.

Scope My Cloud Pen Test See all services